IRLAB Therapeutics AB
Position | Amount | ||||||||
---|---|---|---|---|---|---|---|---|---|
2019-07-10 | IRLAB Therapeutics AB | Anders Vedin | Styrelseledamot/suppleant | Exchange decrease | 19 478 | 92,18 | SEK | 1 795 482,04 | 2019-07-09 |
2019-07-10 | IRLAB Therapeutics AB | Peder Svensson | Director of Computational Chemistry & Biology, CIO | Exchange increase | 31 299 | 92,18 | SEK | 2 885 141,82 | 2019-07-09 |
2019-07-10 | IRLAB Therapeutics AB | Peder Svensson | Director of Computational Chemistry & Biology, CIO | Exchange decrease | 31 299 | 92,18 | SEK | 2 885 141,82 | 2019-07-09 |
2019-07-11 | IRLAB Therapeutics AB | Eva Lindgren | Styrelseledamot/suppleant | Exchange decrease | 19 384 | 88,71 | SEK | 1 719 554,64 | 2019-07-09 |
2019-07-11 | IRLAB Therapeutics AB | Eva Lindgren | Styrelseledamot/suppleant | Exchange increase | 19 384 | 88,71 | SEK | 1 719 554,64 | 2019-07-09 |
2019-07-11 | IRLAB Therapeutics AB | Rein Piir | Närstående | Exchange increase | 19 478 | 92,18 | SEK | 1 795 482,04 | 2019-07-09 |
2019-07-11 | IRLAB Therapeutics AB | Rein Piir | Närstående | Exchange decrease | 19 478 | 92,18 | SEK | 1 795 482,04 | 2019-07-09 |
2019-09-05 | IRLAB Therapeutics AB | Viktor Siewertz | CFO | Acquisition | 2 000 | 31,78 | SEK | 63 560 | 2019-09-04 |
2019-09-05 | IRLAB Therapeutics AB | Anders Vedin | Styrelseledamot/suppleant | Acquisition | 10 000 | 32 | SEK | 320 000 | 2019-09-04 |
2019-09-05 | IRLAB Therapeutics AB | Lena Torlegård | Styrelseledamot/suppleant | Acquisition | 2 800 | 32 | SEK | 89 600 | 2019-09-04 |
2019-09-10 | IRLAB Therapeutics AB | Lena Torlegård | Styrelseledamot/suppleant | Acquisition | 1 450 | 36,7 | SEK | 53 215 | 2019-09-09 |
2019-09-10 | IRLAB Therapeutics AB | Hans Olov Sören Olsson | Styrelseledamot/suppleant | Acquisition | 6 000 | 37,404 | SEK | 224 426,4 | 2019-09-08 |
2019-09-12 | IRLAB Therapeutics AB | Maria Margareta Linnéa Jalmelid | Chief of Clinical Operations | Acquisition | 1 916 | 39,1 | SEK | 74 915,6 | 2019-09-11 |
2020-02-17 | IRLAB Therapeutics AB | Anders Vedin | Styrelseledamot/suppleant | Acquisition | 253 545 | 0 | SEK | 0 | 2020-02-05 |
2020-02-17 | IRLAB Therapeutics AB | Anders Vedin | Styrelseledamot/suppleant | Disposal | 243 446 | 0,09 | SEK | 21 910,14 | 2020-02-16 |
2020-02-25 | IRLAB Therapeutics AB | Anders Vedin | Styrelseledamot/suppleant | Disposal | 3 | 0 | SEK | 0 | 2020-02-23 |
2020-02-25 | IRLAB Therapeutics AB | Anders Vedin | Styrelseledamot/suppleant | Subscription | 1 262 | 27 | SEK | 34 074 | 2020-02-23 |
2020-02-26 | IRLAB Therapeutics AB | Cecilia Tivert Stenberg | Ekonomi/finanschef | Acquisition | 3 500 | 27 | SEK | 94 500 | 2020-02-24 |
2020-02-26 | IRLAB Therapeutics AB | Viktor Siewertz | CFO | Subscription | 2 500 | 27 | SEK | 67 500 | 2020-02-24 |
2020-02-26 | IRLAB Therapeutics AB | Viktor Siewertz | CFO | Subscription | 12 125 | 27 | SEK | 327 375 | 2020-02-24 |